Verastem (VSTM) EPS (Weighted Average and Diluted): 2018-2025

Historic EPS (Weighted Average and Diluted) for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to -$1.35.

  • Verastem's EPS (Weighted Average and Diluted) fell 125.00% to -$1.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.48, marking a year-over-year decrease of 53.42%. This contributed to the annual value of -$3.66 for FY2024, which is 7.58% up from last year.
  • As of Q3 2025, Verastem's EPS (Weighted Average and Diluted) stood at -$1.35, which was down 117.74% from -$0.62 recorded in Q2 2025.
  • Verastem's 5-year EPS (Weighted Average and Diluted) high stood at -$0.08 for Q1 2023, and its period low was -$4.59 during Q4 2021.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.85 (2023), whereas its average is -$0.89.
  • As far as peak fluctuations go, Verastem's EPS (Weighted Average and Diluted) crashed by 3,725.00% in 2021, and later skyrocketed by 77.37% in 2024.
  • Verastem's EPS (Weighted Average and Diluted) (Quarterly) stood at -$4.59 in 2021, then increased by 6.97% to -$4.27 in 2022, then plummeted by 733.33% to -$0.75 in 2023, then grew by 20.00% to -$1.55 in 2024, then crashed by 125.00% to -$1.35 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$1.35 in Q3 2025, compared to -$0.62 in Q2 2025 and -$0.96 in Q1 2025.